Avoidable Bard IVC Filter Injuries

Posted on June 18, 2016

Retrievable Inferior Vena Cava (IVC) filters designed and manufactured by C.R. Bard have come under increased scrutiny over the past few years. This is due to their habit of breaking free from their insertion points and migrating toward other parts of the body, where they can become embedded in the soft tissue of other organs in the body.

IVC filters are tiny, spider-like contraptions that are inserted into the inferior vena cava (a leg vein that travels directly to the lungs) in patients at risk for pulmonary embolism (a blood clot entering the lungs). Though IVC filters are intended to be retrievable, this becomes virtually impossible once they break free. According to a study published in the Journal of the American Medical Association (JAMA), successful IVC retrieval occurred in less than 10 percent of all patients.

What’s worse is that some of these IVC filter injuries could have been avoided. According to a U.S. Food and Drug Administration (FDA) warning letter dated July 13, 2015, the FDA requested changes in the manufacturing of C.R. Bard’s IVC filters. But, the company failed to make the corrections ordered by the FDA. If you have had a Bard IVC filter inserted to prevent pulmonary embolism and have experienced any adverse side effects, you may have grounds for a medical malpractice and product liability claim.

Contact a Dedicated Pharmaceutical Litigation Attorney

To get a settlement that is worthy of your injuries, it is crucial that you seek the representation of a skilled pharmaceutical litigation attorney. The attorneys at the law offices of Farah & Farah have been representing product liability and medical malpractice injury victims for over 35. We are currently investigating IVC filter related injuries nationwide. Call us today for a free consultation by dialing (800) 533-3555.

  • This field is for validation purposes and should be left unchanged.